Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: Jonathan Schonsheck who wrote (4085)	1/15/1999 11:47:00 AM
From: Hank	Respond to of 4342

Jonathan, Most drug companies require substantial experimental data before they will put any money behind a potential drug. Once they are convinced that it is worth the effort, they take on the responsibility of developing the drug for subsequent development. The question is, does PRLN have enough data to convince them at this point? Hopefully, the mice will do their job and give them all the data they will need. I would prefer to wait until they have successfully either 1) documented substantial and reoccurring profits from BioFit and/or 2) successfully nailed down a license agreement with a big drug company before I buy back in. Sure, I would be buying at a higher price at that point but at least I'd more confidence in PRLN's future. Discretion is the better part of valor where companies like PRLN are concerned. We should have all learned that after what happened the last time around. At this point, they are still speculative IMHO. Hank